By Tom Snee 4/18/16
A University of Iowa spinout company that invented a device allowing physically impaired patients to communicate with health care providers expects to launch its product this summer after receiving significant investor interest during clinical trials.
Coralville-based KemPharm's shares are ending the week on a strong note following a big price spike on Wednesday.
The company's chief focus is on developing painkillers that, unlike conventional opiod painkillers, are non-addictive. The FDA accepted an Investigational New Drug Application from KemPharm for KP511, an abuse-deterrent extended release opioid painkiller, at the end of last month.
President Obama announced government plans to spend some $1 billion to fight the opioid addiction crisis on March 29 at the National Rx Drug Abuse and Heroid Summit in Atlanta.
Stanley Consultants representatives were on hand in St. Catherine, Jamaica, on March 23 to celebrate the grand opening of the North-South Highway. This 41-mile section completes the link between the capital city of Kingston in the south with the tourist city of Ocho Rios in the north. A drive that formerly took two hours on a substandard road can now be completed in less than 60 minutes on a new four-lane highway built to international standards.
Viewpoint Molecular Targeting of Coralville was awarded the Iowa Biotechnology Association's top award at this year's Partnering For Growth Biotech Innovation Showcase, held March 30-31 in Ankeny.
Voxello, the producer of the noddle, a medical device that helps impaired patients to communicate with nurses and caregivers, continued its efforts to promote the company's marquee product at a venture capital forum in St. Louis.
The company was among nearly four dozen startups that pitched their ideas at the InvestMidWest Venture Capital Forum, held late last month. According to the forum's organizers, InvestMidwest has helped generate more than $1 billion in investments and acquisitions for its companies since the first forum was held in 2000.
SantosHuman (SHI), a company that grew out of ongoing research at the University of Iowa, has begun working with the Netherlands Organization for Applied Scientific Research (TNO) to enhance effectiveness and reduce injuries among that country’s military members.
Coralville-based biotech company KemPharm announced Wednesday that its first drug submitted to the U.S. Food and Drug Administration (FDA) has been granted priority review, and should be more closely examined by regulators by June.
Modern Healthcare magazine this year named MediRevv the 76th best place to work in health care, marking the third time the Coralville company has appeared as one of the magazine's top 100 employers.